Equities

Biofrontera Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
BFRI:NAQ

Biofrontera Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.7626
  • Today's Change-0.017 / -2.24%
  • Shares traded457.69k
  • 1 Year change-30.04%
  • Beta0.6438
Data delayed at least 15 minutes, as of Feb 11 2026 19:43 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Key statistics

As of last trade, Biofrontera Inc (BFRI:NAQ) traded at 0.7626, 42.27% above the 52 week low of 0.536 set on May 30, 2025.
52-week range
Today
0.536May 30 20251.19Nov 06 2025
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.832
High0.848
Low0.73
Bid0.7473
Offer0.7779
Previous close0.78
Average volume1.68m
Shares outstanding11.65m
Free float10.17m
P/E (TTM)--
Market cap9.09m USD
EPS (TTM)-1.84
USD
Data delayed at least 15 minutes, as of Feb 11 2026 19:43 GMT.
More ▼

Events & Activity

  • BFRI:NAQ trading volume exceeds daily average by +1,387.58%
  • BFRI:NAQ price moved over +13.78% to 0.9341
  • BFRI:NAQ price rises above 200-day moving average to 0.848 at 14:31 GMT
  • BFRI:NAQ price rises above 200-day moving average to 0.9341 at 14:30 GMT
  • BFRI:NAQ price rises above 50-day moving average to 0.832 at 14:30 GMT
  • BFRI:NAQ price rises above 50-day moving average to 0.9341 at 14:30 GMT
  • BFRI:NAQ price rises above 15-day moving average to 0.9341 at 14:30 GMT
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.